Item 8.01 Other Events

On January 5, 2022, Marizyme, Inc. (the "Company") issued a press release to announce that the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for the Company's DuraGraft related patent application entitled "Solutions for Increasing the Stability and Shelf Life of an Organ and Tissue Preservation Solution." The allowed patent application No. 14/906,582 covers an organ and tissue preservation kit containing shelf-life stable solutions used for vascular graft and tissue protection and preservation during coronary artery bypass surgery (CABG) and other vascular surgeries.

Item 9.01 Financial Statements and Exhibits





(d) Exhibits

The following exhibits are filed herewith:





Exhibit
  No.     Description of Exhibit
 99.1       Press Release dated January 5, 2022.
  104     Cover Page Interactive Data File (embedded within the Inline XBRL
          document)




                           [Signature page follows.]



2

© Edgar Online, source Glimpses